AR066371A1 - Formulaciones de aminoacidos n-halogenados que contienen acidos alifaticos - Google Patents
Formulaciones de aminoacidos n-halogenados que contienen acidos alifaticosInfo
- Publication number
- AR066371A1 AR066371A1 ARP080101842A ARP080101842A AR066371A1 AR 066371 A1 AR066371 A1 AR 066371A1 AR P080101842 A ARP080101842 A AR P080101842A AR P080101842 A ARP080101842 A AR P080101842A AR 066371 A1 AR066371 A1 AR 066371A1
- Authority
- AR
- Argentina
- Prior art keywords
- halogenated amino
- formulations
- alifatic
- acids
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Eyeglasses (AREA)
Abstract
Métodos para el tratamiento de un tejido infectado, que comprenden el tratamiento del tejido infectado con una formulacion que comprende un aminoácido N-halogenado y un ácido alifático. Métodos para mejorar la actividad antimicrobiana de unaformulacion que comprende un aminoácido N-halogenado, donde el método comprende la adicion de un ácido alifático a dicha formulacion. Reivindicacion 2: El método de la reivindicacion 1, donde el ácido alifático se selecciona del grupo que consisteen: acetato de sodio, acetato de potasio, acetato de calcio, acetato de magnesio, ácido butírico y sus combinaciones. Reivindicacion 3: El método de la reivindicacion 1, donde el aminoácido N-halogenado es una clorotaurina. Reivindicacion 4: Elmétodo de la reivindicacion 3, donde la clorotaurina es 2,2-dimetil-N,N-diclorotaurina de sodio.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91527107P | 2007-05-01 | 2007-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR066371A1 true AR066371A1 (es) | 2009-08-12 |
Family
ID=39616420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080101842A AR066371A1 (es) | 2007-05-01 | 2008-04-30 | Formulaciones de aminoacidos n-halogenados que contienen acidos alifaticos |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20080275126A1 (es) |
| EP (1) | EP2139520B1 (es) |
| JP (2) | JP2010526084A (es) |
| KR (1) | KR20100017156A (es) |
| CN (1) | CN101678105A (es) |
| AR (1) | AR066371A1 (es) |
| AU (1) | AU2008245460B2 (es) |
| BR (1) | BRPI0811073A2 (es) |
| CA (1) | CA2684101A1 (es) |
| CL (1) | CL2008001283A1 (es) |
| ES (1) | ES2432408T3 (es) |
| MX (1) | MX2009011817A (es) |
| RU (1) | RU2009144291A (es) |
| TW (1) | TW200902092A (es) |
| UY (1) | UY31057A1 (es) |
| WO (1) | WO2008134692A1 (es) |
| ZA (1) | ZA200907052B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110151025A1 (en) * | 2008-04-10 | 2011-06-23 | Novabay Pharmaceuticals, Inc. | Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections |
| US20110091570A1 (en) * | 2008-04-15 | 2011-04-21 | Waldemar Gottardi | Compositions and Devices for Antisepsis and Anticoagulation |
| CN113729039A (zh) * | 2021-08-27 | 2021-12-03 | 上海罗克环控节能科技股份有限公司 | 一种绿色环保消毒液及其制造方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6027965B2 (ja) * | 1980-02-23 | 1985-07-02 | 東洋コンタクトレンズ株式会社 | コンタクトレンズに付着した汚れの除去方法 |
| US5421818A (en) * | 1993-10-18 | 1995-06-06 | Inner Ear Medical Delivery Systems, Inc. | Multi-functional inner ear treatment and diagnostic system |
| AU3070395A (en) * | 1994-07-22 | 1996-02-22 | Alcon Laboratories, Inc. | Use of low molecular weight amino acids in ophthalmic compositions |
| US6156728A (en) * | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
| US6387427B1 (en) * | 2000-09-28 | 2002-05-14 | Nestec S.A. | Method of preservation of a food product |
| EP1469860A4 (en) * | 2002-01-24 | 2005-09-07 | Yissum Res Dev Co | ANTICANCER COMBINATION AND USE THEREOF |
| SI1656095T1 (sl) * | 2003-08-18 | 2014-04-30 | Nobabay Pharmaceuticals, Inc. | N,n-dihalogenirane aminokisline in derivati |
| TWI386201B (zh) * | 2005-01-25 | 2013-02-21 | Novabay Pharmaceuticals Inc | Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法 |
| EP1948154A1 (en) * | 2005-10-06 | 2008-07-30 | Novabay Pharmaceuticals, Inc. | System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids |
-
2008
- 2008-04-29 UY UY31057A patent/UY31057A1/es unknown
- 2008-04-30 TW TW097115864A patent/TW200902092A/zh unknown
- 2008-04-30 EP EP08795826.0A patent/EP2139520B1/en not_active Not-in-force
- 2008-04-30 CN CN200880014268A patent/CN101678105A/zh active Pending
- 2008-04-30 MX MX2009011817A patent/MX2009011817A/es not_active Application Discontinuation
- 2008-04-30 US US12/112,370 patent/US20080275126A1/en not_active Abandoned
- 2008-04-30 CA CA002684101A patent/CA2684101A1/en not_active Abandoned
- 2008-04-30 AU AU2008245460A patent/AU2008245460B2/en not_active Ceased
- 2008-04-30 JP JP2010506585A patent/JP2010526084A/ja not_active Withdrawn
- 2008-04-30 AR ARP080101842A patent/AR066371A1/es unknown
- 2008-04-30 RU RU2009144291/15A patent/RU2009144291A/ru not_active Application Discontinuation
- 2008-04-30 WO PCT/US2008/061950 patent/WO2008134692A1/en active Application Filing
- 2008-04-30 KR KR1020097024156A patent/KR20100017156A/ko not_active Application Discontinuation
- 2008-04-30 ES ES08795826T patent/ES2432408T3/es active Active
- 2008-04-30 BR BRPI0811073-5A2A patent/BRPI0811073A2/pt not_active IP Right Cessation
- 2008-05-02 CL CL2008001283A patent/CL2008001283A1/es unknown
-
2009
- 2009-10-09 ZA ZA2009/07052A patent/ZA200907052B/en unknown
-
2010
- 2010-11-16 US US12/947,740 patent/US20110060044A1/en not_active Abandoned
-
2014
- 2014-02-28 JP JP2014037949A patent/JP2014098037A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008134692A1 (en) | 2008-11-06 |
| CL2008001283A1 (es) | 2009-01-16 |
| CA2684101A1 (en) | 2008-11-06 |
| UY31057A1 (es) | 2008-10-31 |
| MX2009011817A (es) | 2009-11-13 |
| TW200902092A (en) | 2009-01-16 |
| EP2139520A1 (en) | 2010-01-06 |
| CN101678105A (zh) | 2010-03-24 |
| JP2014098037A (ja) | 2014-05-29 |
| ZA200907052B (en) | 2010-12-29 |
| US20110060044A1 (en) | 2011-03-10 |
| KR20100017156A (ko) | 2010-02-16 |
| AU2008245460B2 (en) | 2013-08-22 |
| EP2139520B1 (en) | 2013-08-21 |
| JP2010526084A (ja) | 2010-07-29 |
| BRPI0811073A2 (pt) | 2014-12-09 |
| RU2009144291A (ru) | 2011-06-10 |
| AU2008245460A1 (en) | 2008-11-06 |
| ES2432408T3 (es) | 2013-12-03 |
| US20080275126A1 (en) | 2008-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR11648A (es) | Composicion que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes acidas | |
| PE20190914A1 (es) | Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico | |
| AR084433A1 (es) | Inhibidores de la faah y composiciones farmaceuticas que los contienen | |
| BRPI0811948A2 (pt) | Novo agente para a liberação de princípios ativos em curativos que contenham ao menos uma susbtância gordurosa | |
| AR054805A1 (es) | Composiciones topicas para el tratamiento de la piel | |
| ATE469674T1 (de) | 5-aminolävulinsäure-derivate zur behandlung von akne | |
| CY1111170T1 (el) | Ενωσεις διαρυλ αιθερα ουριας | |
| BR112012023421A2 (pt) | composição farmacêutica para tratamento de aumento de pressão intraocular | |
| BRPI0512347B8 (pt) | preparação da pregabalina e compostos relacionados | |
| EA201291436A1 (ru) | Производные гексафторизопропил карбамата, их получение и их терапевтическое применение | |
| EA201190144A1 (ru) | Изотиазолилоксифениламидины и их применение в качестве фунгицидов | |
| EA200800777A1 (ru) | Применение сложных эфиров молочной кислоты для улучшения действия пестицидов | |
| EA201100863A1 (ru) | Фармацевтическая композиция, включающая диклофенак и сложный эфир гидроксижирной кислоты и полиоксиалкилена | |
| EA200900732A1 (ru) | Кристаллическая калиевая соль аналогов липоксина а | |
| PE20221458A1 (es) | Composiciones solidas que comprenden un inhibidor de pcsk9 y una sal de acido n-(8-(2-hidroxibenzoil)amino)caprilico | |
| UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
| CO6280474A2 (es) | Composicion farmaceutica para el tratamiento de la eyaculacion precoz | |
| AR124078A1 (es) | Método para el tratamiento de la enfermedad de parkinson | |
| PE20061435A1 (es) | Derivados de alfa-aminoacidos como ligandos del receptor alfa-2-delta | |
| AR075097A1 (es) | Sales y formas polimorficas cristalinas de [4-(6-fluoro-7-metilamino-2,4-dioxo-1,4-dihidro-2h-quinazolin-3-il)-fenil]-5-cloro-tiofen-2-il-sulfonil urea, composiciones farmaceuticas que las contiene, metodo para prepararlas y uso de las mismas en el tratamiento de enfermedades cardiovasculares asocia | |
| AR066371A1 (es) | Formulaciones de aminoacidos n-halogenados que contienen acidos alifaticos | |
| AR066373A1 (es) | Formulaciones de aminoacidos n-halogenados | |
| AR066372A1 (es) | Formulaciones de aminoacidos n-halogenados con compuestos antiinflamatorios | |
| AR058053A1 (es) | Formas cristalinas polimorficas de la sal de di- sodio del acido n- (5 -clorosaliciloil)-8- aminocaprilico | |
| AR072917A1 (es) | Composiciones para el tratamiento de la rosacea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |